Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Editorial Volume 7 Issue 2

Medication Adherence: Fact or Fictions?

Abdul Kader Mohiuddin*

Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh

*Corresponding Author: Abdul Kader Mohiuddin, Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh.

Received: November 03, 2022; Published: January 01, 2023

Abstract

Abbreviations

ADEs: Adverse Drug Events; NSAIDs: Non-Steroidal Anti-Inflammatory Drugs; CDC: The Centers for Disease Control and Prevention; WHO: World Health Organization

Keywords: Patient Compliance; Healthcare Denials; Medication Adherence; Elderly Patient Care; Treatment Failure

References

  1. Grissinger M. “The Five Rights: A Destination Without a Map”. P T10 (2010): 542.
  2. Brown MT and Bussell JK. “Medication adherence: WHO cares?” Mayo Clinic Proceedings 4 (2011): 304-314.
  3. Center for Drug Evaluation and Research. (n.d.). “Why you need to take your medications as prescribed or instructed”. U.S. Food and Drug Administration (2022).
  4. Barnett NL. “Medication adherence: where are we now? A UK perspective”. European Journal of Hospital Pharmacy: Science and Practice 21 (2014): 181-184.
  5. Campbell Denis and Pamela Duncan. “Record 6.8m People Waiting for Hospital Treatment in England”. The Guardian, 8 Sept. (2022).
  6. Andrews Luke. “60% of Patients Waiting 18 Wks for Treatment at Worst-performing Trust”. Mail Online, 7 Mar (2022).
  7. Cutler RL., et al. “Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system”. Patient Prefer Adherence 13 (2019): 853-862.
  8. Bonsu KO., et al. “Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada - A Cross-Sectional Survey”. Patient Prefer Adherence 16 (2022): 1771-1780.
  9. Furniss D., et al. “Unintentional non-adherence: can a spoon full of resilience help the medicine go down?” BMJ Quality Safety2 (2014): 95-98.
  10. Bahta M., et al. “Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: A simulated client method”. PLoS One1 (2020): e0228013.
  11. “Improve Antibiotic Use.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 9 Mar (2022).
  12. Antimicrobial Resistance Collaborators. “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis”. Lancet10325 (2022): 629-655.
  13. Kasciuškevičiūtė S., et al. “Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study”. Medicina (Kaunas) 54.2 (2018): 30.
  14. Lucas GNC., et al. “Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs”. Brazilian Journal of Nephrology 1 (2019): 124-130.
  15. Jahrami H., et al. “Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis”. Journal of Clinical Sleep Medicine 2 (2021): 299-313.
  16. Ostuzzi G., et al. “Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations”. BMC Medicine1 (2000): 215.
  17. Bhadelia A., et al. “Solving the Global Crisis in Access to Pain Relief: Lessons From Country Actions”. American Journal of Public Health1 (2019): 58-60.
  18. Chauke GD., et al. “Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review”. Heliyon 6 (2022): e09716.
  19. Chong E., et al. “Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with Type 2 diabetes mellitus: a population-based cohort study”. Diabetics Medicine (2014).
  20. Sohal T., et al. “Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review”. PLoS One9 (2015): e0136202.
  21. Félix IB and Henriques A. “Medication adherence and related determinants in older people with multimorbidity: a cross‐sectional study”. Nursing Forum 56 (2021): 834-843.
  22. Chippa V and Roy K. “Geriatric Cognitive Decline and Polypharmacy”. In: StatPearls. Treasure Island (FL): StatPearls Publishing (2022).
  23. Varghese D., et al. “Polypharmacy”. In: StatPearls. Treasure Island (FL): StatPearls Publishing (2022).
  24. Choudhry NK., et al. “Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association”. Hypertension1 (2022): e1-e14.
  25. Alsairafi ZK., et al. “Patients' management of type 2 diabetes in Middle Eastern countries: review of studies”. Patient Prefer Adherence 10 (2016): 1051-1062.
  26. Lossius M I., et al. “Seponering av Antiepileptika Ved anfallsfrihet - når og hvordan?” Tidsskrift for Den Norske Legeforening6 (2017): 451-454.
  27. Jin J., et al. “Factors affecting therapeutic compliance: A review from the patient's perspective”. Therapeutics and Clinical Risk Management1 (2008): 269-286.

Citation

Citation: Abdul Kader Mohiuddin. “Medication Adherence: Fact or Fictions?". Acta Scientific Pharmaceutical Sciences 7.2 (2023): 01-03.

Copyright

Copyright: © 2022 Abdul Kader Mohiuddin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


Contact US